Russell Investments Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.07M | Buy |
29,367
+5,621
| +24% | +$970K | 0.01% | 1205 |
|
|
2025
Q1 | $3.7M | Buy |
23,746
+20,532
| +639% | +$3.2M | 0.01% | 1337 |
|
|
2024
Q4 | $442K | Buy |
3,214
+6
| +0.2% | +$826 | ﹤0.01% | 2310 |
|
|
2024
Q3 | $479K | Hold |
3,208
| – | – | ﹤0.01% | 2288 |
|
|
2024
Q2 | $438K | Hold |
3,208
| – | – | ﹤0.01% | 2247 |
|
|
2024
Q1 | $485K | Hold |
3,208
| – | – | ﹤0.01% | 2209 |
|
|
2023
Q4 | $404K | Sell |
3,208
-4,166
| -56% | -$525K | ﹤0.01% | 2288 |
|
|
2023
Q3 | $691K | Sell |
7,374
-40,252
| -85% | -$3.77M | ﹤0.01% | 2107 |
|
|
2023
Q2 | $4.25M | Sell |
47,626
-6,577
| -12% | -$587K | 0.01% | 1167 |
|
|
2023
Q1 | $5.81M | Sell |
54,203
-4,760
| -8% | -$510K | 0.01% | 1038 |
|
|
2022
Q4 | $7.2M | Sell |
58,963
-7,239
| -11% | -$884K | 0.01% | 915 |
|
|
2022
Q3 | $6.83M | Buy |
66,202
+16,970
| +34% | +$1.75M | 0.02% | 900 |
|
|
2022
Q2 | $4.58M | Buy |
49,232
+12,447
| +34% | +$1.16M | 0.01% | 1145 |
|
|
2022
Q1 | $4.32M | Buy |
36,785
+10,332
| +39% | +$1.21M | 0.01% | 1244 |
|
|
2021
Q4 | $3.56M | Buy |
26,453
+998
| +4% | +$134K | 0.01% | 1471 |
|
|
2021
Q3 | $4.06M | Buy |
25,455
+5,214
| +26% | +$831K | 0.01% | 1373 |
|
|
2021
Q2 | $2.66M | Buy |
+20,241
| New | +$2.66M | ﹤0.01% | 1743 |
|